Private Capital Management (Minnesota)’s Pfizer PFE Stock Holding History

Private Capital Management (Minnesota)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$989K	Sell	29,196 -1,897	-6%	-$61K	1.11%	17
2017 Q2	$991K	Hold	31,093	–	–	1.1%	18
2017 Q1	$1.01M	Hold	31,093	–	–	1.1%	18
2016 Q4	$958K	Sell	31,093 -4,954	-14%	-$151K	1.07%	19
2016 Q3	$1.16M	Sell	36,047 -5,902	-14%	-$197K	1.22%	11
2016 Q2	$1.4M	Sell	41,949 -5,692	-12%	-$182K	1.38%	5
2016 Q1	$1.34M	Buy	47,641 +5,270	+12%	+$151K	1.23%	9
2015 Q4	$1.3M	Buy	+42,371	New	+$1.33M	1.2%	10

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Private Capital Management (Minnesota)'s PFE Position: Q3 2017 in Review

Private Capital Management (Minnesota) reduced its Pfizer (PFE) stake by 6.1% in Q3 2017, selling an estimated $61K and leaving 29,196 shares worth $989K. The position accounts for 1.11% of the portfolio, ranked #17.

Private Capital Management (Minnesota) first reported a position in PFE in Q4 2015 and has held it in 8 quarters since. The position peaked at $1.4M in Q2 2016. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

Private Capital Management (Minnesota) held 29,196 shares of Pfizer worth $989K as of Q3 2017.
Private Capital Management (Minnesota) sold 1,897 Pfizer shares in Q3 2017, an estimated $61K.
Pfizer made up 1.11% of Private Capital Management (Minnesota)'s portfolio in Q3 2017, its #17 holding.
Private Capital Management (Minnesota) first reported a position in Pfizer in Q4 2015 and has held it in 8 quarters since.
Private Capital Management (Minnesota)'s Pfizer position peaked at $1.4M in Q2 2016.
2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Private Capital Management (Minnesota)'s 13F filing for Q3 2017, filed 26 Oct 2017.